Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03130218 · ClinicalTrials.gov registry record · NA

Aromatherapy in Management of Postoperative Nausea in Post-Bariatric Surgery Patients

A NA study, sponsored by Lancaster General Hospital.

Completed
Registry status
NA
Development phase
204
Enrollment target

NCT03130218 is a NA study that has completed, run by Lancaster General Hospital. The registered enrollment target is 204 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03130218, a NA study, has completed, sponsored by Lancaster General Hospital.

COMPLETED
Registry status
NA
Development phase
204 participants
Enrollment target

Study Summary

Determine the effectiveness of peppermint oil aromatherapy in relieving post-operative nausea in the bariatric surgery patient population.

Interventions

  • OTHER Peppermint oil aromatherapy

Trial Details

FieldValue
Enrollment Target 204 participants
Start Date 2017-06-08
Est. Completion 2019-12-31
Phase NA

Sponsor

Lancaster General Hospital

15 total trials

What the Registry Record Tells You About NCT03130218

The ClinicalTrials.gov registry entry for NCT03130218 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 204 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Lancaster General Hospital, which has 15 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Peppermint oil aromatherapy is the first listed.

NCT03130218 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT03130218 about?

NCT03130218 is a clinical study titled "Aromatherapy in Management of Postoperative Nausea in Post-Bariatric Surgery Patients". Determine the effectiveness of peppermint oil aromatherapy in relieving post-operative nausea in the bariatric surgery patient population.

What is the current status of trial NCT03130218?

This trial is currently completed. It is a NA study. The enrollment target is 204 participants. The study started on 2017-06-08. Estimated completion is 2019-12-31.

What interventions are being tested in trial NCT03130218?

The interventions under investigation include: Peppermint oil aromatherapy (OTHER).

Who is sponsoring clinical trial NCT03130218?

This trial is sponsored by Lancaster General Hospital, which has 15 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.